Your search returned 2 results.

Results
	1.	Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial. [electronic resource] by Genovese, M C Bojin, S Biagini, I M Mociran, E Cristei, D Mirea, G Georgescu, L Sloan-Lancaster, J Producer: 20130522 In: Arthritis and rheumatism vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. [electronic resource] by Genovese, M C Van den Bosch, F Roberson, S A Bojin, S Biagini, I M Ryan, Peter Sloan-Lancaster, J Producer: 20100504 In: Arthritis and rheumatism vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search